Table 2.
- Demographic and clinical characteristics of subjects (N=105).
| Characteristics | n (%) |
|---|---|
| Age | |
| 1-20 | 9 (8.6) |
| 21-40 | 47 (44.8) |
| 41-60 | 25 (23.8) |
| 61-90 | 24 (22.9) |
| Mean | 42.93 |
| Median x-bar | 38.00 |
| Standard deviation | 21.329 |
| Gender | |
| Male | 68 (64.8) |
| Female | 37 (35.2) |
| Nationality | |
| Saudi | 85 (81.0) |
| Non-Saudi | 19 (18.1) |
| Not mentioned | 1 (0.9) |
| Comorbidities | |
| Diabetes mellitus | 28 (26.7) |
| Hypertension | 22 (21.0) |
| Ischemic heart disease | 8 (7.6) |
| Human immunodeficiency virus | 1 (0.95) |
| Malignancy | 7 (6.7) |
| Immunosuppression | 5 (4.8) |
| Other comorbidities | 30 (28.6) |
| No comorbidities | 50 (47.6) |
| Previous treatment for tuberculosis | |
| Yes | 6 (5.7) |
| No | 99 (94.3) |
| Site of infection | |
| Unknown | 6 (5.7) |
| Pulmonary | 39 (37.1) |
| Extrapulmonary | 34 (32.4) |
| Disseminated* | 26 (24.8) |
Values are presented as numbers and percentages (%).
*
Disseminated infection involves both the pulmonary and extrapulmonary systems. HIV: Human immunodeficiency virus